Analysis of medication therapy discontinuation orders in new electronic prescriptions and opportunities for implementing CancelRx.

Yuze Yang¹, Stacy Ward-Charlerie¹, Nitu Kashyap², Richelle DeMayo³, Thomas Agresta^4,5,6, James Green¹

¹Surescripts LLC, Arlington, Virginia, USA.

²Clinical Informatics, Yale New Haven Health System, New Haven, Connecticut, USA.

³Connecticut Children's Medical Center, Hartford, Connecticut, USA.

⁴Clinical Informatics, Farmington, Connecticut, USA.

⁵Connecticut Institute for Primary Care Innovation, Hartford, Connecticut, USA.

⁶University of Connecticut, Storrs, Connecticut, USA.

PubMed PMC DOI PDF

Abstract

OBJECTIVE: To illustrate the need for wider implementation of the CancelRx message by quantifying and characterizing the inappropriate usage of new electronic prescription (NewRx) messages for communicating discontinuation instructions to pharmacies. MATERIALS AND METHODS: A retrospective analysis on a nationally representative random sample of 1 400 000 NewRx messages transmitted over 7 days to…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.